Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patientsA manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patientsSEONGNAM and SEOUL, South Korea,…

Read the full release →

News provided by PR Newswire.